Arena Pharmaceuticals has announced positive results for the Phase II clinical trials of APD125, a drug designed for patients with chronic insomnia.
U. of Michigan researchers discover why opiate-based painkillers for fibromyalgia, a condition marked by pain, nausea, and fatigue, are often ineffective.
A popular narcolepsy drug has been linked with at least five different skin diseases, according to the most recent FDA Drug Safety Newsletter.
Board of Registered Polysomnographic Technologists (BRPT) and the National Sleep Foundation (NSF) unveil Patients Guide to Sleep Evaluations.
The SAFER program did not improve sleep hygiene among medical interns.
Alexza Pharmaceuticals, makers of a promising new insomnia drug, have named Robert S. Fishman as vice president, medical affairs.
Texas company creates absorbent underpants that look and feel like boxer-style underwear to minimize bedwetting tendencies in children.
Cephalon Inc, Frazer, Pa, has finalized revisions to the label for Provigil (modafinil), its wake-promoting agent.
A new study presented this week in Washington, DC, touts the virtues of bipolar radiofrequency ablation removal.
REM may contribute to the consolidation of hippocampus-dependent memories due to synchronization of EEG rhythms.